mitomycin has been researched along with 11-acetyl-8-carbamoyloxymethyl,4-formyl-6-methoxy-14-oxa-1,11-diazatetracyclo(7.4.1.0.0)tetradeca-2,4,6-trien-9-yl acetate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Miyayasu, K; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S | 1 |
| Fujiwara, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S; Yamazaki, S | 1 |
| Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S | 1 |
| Goto, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Matsuo, M; Naoe, Y; Nishigaki, F; Sasakawa, Y; Tsujimoto, S | 1 |
4 other study(ies) available for mitomycin and 11-acetyl-8-carbamoyloxymethyl,4-formyl-6-methoxy-14-oxa-1,11-diazatetracyclo(7.4.1.0.0)tetradeca-2,4,6-trien-9-yl acetate
| Article | Year |
|---|---|
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1998 |
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biotransformation; Body Weight; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Oxazines; Stomach Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1998 |
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Glucose; Body Weight; Cachexia; Carcinoma; Colonic Neoplasms; Drug Screening Assays, Antitumor; Epididymis; Fatty Acids, Nonesterified; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Muscle, Skeletal; Organ Size; Oxazines; Triglycerides | 1998 |
Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Drug Evaluation; Female; Melanoma, Experimental; Mice; Mice, Inbred Strains; Mitomycin; Oxazines; Survival Analysis | 2002 |